Market Insights Health OTC Pharmaceuticals

Wound Care - EU-27

EU-27

In the EU-27, the Wound Care market market generated a revenue of US$0.92bn in 2024.
It is projected to experience an annual growth rate of 0.22% (CAGR 2024-2029).
When compared to the global market, the in the United States leads with a revenue of US$1,052.00m in 2024.
On a per person basis, the revenue generated in the EU-27 amounts to US$2.05 in 2024.
In the EU-27, Germany is leading the way in the wound care market with innovative and advanced products.

Key regions: Australia, Europe, Canada, United States, Japan

Market

Region

Region comparison

Currency

Analyst Opinion

The Wound Care market in EU-27 is experiencing steady growth due to increasing customer preferences for advanced wound care products and treatments.

Customer preferences: Customers in the EU-27 are increasingly seeking advanced wound care products and treatments that offer faster healing, reduced pain, and improved quality of life. This shift in preferences can be attributed to the aging population, rising prevalence of chronic diseases, and growing awareness about the importance of wound care. Additionally, customers are also looking for products that are easy to use, cost-effective, and have minimal side effects.

Trends in the market: One of the key trends in the Wound Care market in EU-27 is the adoption of advanced wound dressings. These dressings provide a moist wound healing environment, which promotes faster healing and reduces the risk of infection. Customers are also showing a preference for products that incorporate innovative technologies, such as antimicrobial agents and growth factors, which further enhance the healing process. Another trend in the market is the increasing use of negative pressure wound therapy (NPWT) devices. These devices create a vacuum environment that promotes wound healing by removing excess fluid, reducing edema, and stimulating blood flow. NPWT devices are especially beneficial for chronic wounds and complex surgical wounds.

Local special circumstances: The Wound Care market in EU-27 is characterized by a diverse regulatory landscape. Each country within the EU-27 has its own set of regulations and reimbursement policies for wound care products and treatments. This can create challenges for market players, as they need to navigate through different regulatory frameworks and adapt their strategies accordingly. Additionally, the market is also influenced by factors such as cultural preferences, healthcare infrastructure, and availability of healthcare professionals. These local special circumstances can impact the adoption and usage of wound care products and treatments in each country.

Underlying macroeconomic factors: The growth of the Wound Care market in EU-27 is supported by several underlying macroeconomic factors. These include the increasing healthcare expenditure, favorable reimbursement policies, and advancements in healthcare technology. The EU-27 countries have a well-established healthcare system and allocate a significant portion of their GDP to healthcare. This enables customers to have access to a wide range of wound care products and treatments. Furthermore, the favorable reimbursement policies in the region encourage the adoption of advanced wound care solutions. Lastly, advancements in healthcare technology, such as telemedicine and remote patient monitoring, are also driving the growth of the market by improving accessibility and convenience for customers.In conclusion, the Wound Care market in EU-27 is witnessing growth due to increasing customer preferences for advanced wound care products and treatments. The adoption of advanced wound dressings and NPWT devices, along with the diverse regulatory landscape and underlying macroeconomic factors, are shaping the market trends in each country.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.